Gland Pharma Limited
GLAND
Rank in Stocks
#3238
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Share Price
$33.33
Last synced: 2026-10-19
Market Cap
$5.50B
Change (1 day)
-0.68%
Change (1 year)
52.58%
Country
IN
Trade Gland Pharma Limited (GLAND)
Category
Healthcare
Number of shares outstanding for Gland Pharma Limited (GLAND)
Number of shares outstanding as of June 2026: 164.83M
According to Gland Pharma Limited latest financial reports and stock price the company's current number of shares outstanding is 164.83M. At the end of March 2024 the company had 164.74M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Gland Pharma Limited (GLAND) from 2017 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 164.83M | 0.05% |
| 2025 | 164.75M | 0.00% |
| 2024 | 164.74M | 0.04% |
| 2023 | 164.67M | 0.08% |
| 2022 | 164.54M | 3.96% |
| 2021 | 158.27M | 2.15% |
| 2020 | 154.95M | -0.01% |
| 2019 | 154.96M | 0.01% |
| 2018 | 154.95M | 0.00% |
| 2017 | 154.95M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,355.69% |
IN
|
